0002023721-24-000001.txt : 20240520 0002023721-24-000001.hdr.sgml : 20240520 20240520134706 ACCESSION NUMBER: 0002023721-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 EFFECTIVENESS DATE: 20240520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kano Therapeutics Inc. CENTRAL INDEX KEY: 0002023721 ORGANIZATION NAME: IRS NUMBER: 873761770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-513745 FILM NUMBER: 24963620 BUSINESS ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174859448 MAIL ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0002023721 Kano Therapeutics Inc. 238 MAIN STREET CAMBRIDGE MA MASSACHUSETTS 02142 6174859448 DELAWARE None None Corporation true 2021 Floris Engelhardt c/o Kano Therapeutics Inc. 238 Main Street Cambridge MA MASSACHUSETTS 02142 Executive Officer Director John Vroom c/o Kano Therapeutics Inc. 238 Main Street Cambridge MA MASSACHUSETTS 02142 Director Ann DeWitt c/o Kano Therapeutics Inc. 238 Main Street Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2024-05-06 false true false 0 5050000 5050000 0 false 4 0 0 0 false Kano Therapeutics Inc. /s/ Floris Engelhardt Floris Engelhardt Chief Executive Officer 2024-05-20